Table 1 Demographic and clinical data of study patients at baseline
Parameter | Data |
|---|---|
Age (years) | 49 (26–70) |
Male:female ratio | 6:5 |
Duration of joint disease (years) | 9 (1–22) |
Duration of skin disease (years) | 21 (2–41) |
Disease Activity Score | 6.2 (4.8–8.2) |
Tender joint count | 14 (2–26) |
Swollen joint count | 11 (9–21) |
Visual analogue scale for pain | 69 (36–90) |
C-reactive protein (mg/ml) | 26 (7–36) |
Psoriasis Area and Severity Index | 12.2 (1.0–29.8) |
Methotrexate dosage (mg/week) | 10 (5–20) |